Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Mixed Dyslipidemia: Fenostat is indicated as an adjunct to diet to reduce elevated total-C, LDL-C, apoB, and TG levels and to increase HDLC in adult patients with mixed dyslipidemia.
Hypercholesterolemia: Fenostat is indicated as an adjunct to diet to reduce elevated total-C, LDL-C, apoB and to increase HDL-C in adult patients with primary hypercholesterolemia.
Lipid altering agents should be used in addition to diet restricted in saturated fat and cholesterol only when the response to diet and other non-pharmacological measures has been inadequate. (See Table 1.)

Click on icon to see table/diagram/image

After the LDL-C goal has been achieved, if the TG level is still ≥200 mg/dL, non-HDL-C (TC minus HDL-C) becomes a secondary target of therapy. Non-HDL-C goals are set 30 mg/dL higher than LDL-C goals for each risk category.

Fenostat Indications/Uses

Manufacturer:

Ajanta Pharma Phil

Distributor:

Ajanta Pharma Phil